Alkaloid AD Skopje

ALK

MKALKA101011

Pharmaceuticals

End-of-day quote MACEDONIAN S.E. Other stock markets
- ^MKD	-

Jan. 15	Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Alka-Lab announced that it has received €0.4 million in funding from Alkaloid AD

July 22, 2019

Alka-Lab announced that it has received an equity round of funding on July 23, 2019. The transaction included participation from Alkaloid AD.

Latest news about Alkaloid AD Skopje

Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14	CI
Alkaloid AD Skopje Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-26	CI
Alkaloid AD Skopje Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-14	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
Alkaloid AD Skopje Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-14	CI
Alkaloid Ad Skopje Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-29	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI
Alkaloid Ad Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-14	CI
Alkaloid Ad Reports Earnings Results for the Half Year Ended June 30, 2020	20-07-30	CI
Alkaloid Ad Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-30	CI
Alkaloid AD's Equity Buyback announced on March 12, 2020, has expired.	20-04-06	CI
Alkaloid AD(MSE:ALK) commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 8, 2019.	20-03-12	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-28	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-30	CI
Alka-Lab announced that it has received €0.4 million in funding from Alkaloid AD	19-07-22	CI
Alkaloid Ad Reports Earnings Results for the Full Year Ended December 31, 2018	19-02-27	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) acquired an unknown stake in Alkaloid AD.	19-01-23	CI
Alkaloid Ad Skopje Reports Earnings Results for the Nine Months Ended September 30, 2018	18-10-31	CI
Alkaloid Reports Consolidated Earnings Results for the First-Quarter of 2017	17-04-27	CI
Alkaloid Reports Unaudited Consolidated and Standalone Earnings Results for the Year Ended December 2016	17-02-28	CI
Alkaloid Reports Consolidated Financial Results for the First Nine Months Ended September 2016	16-11-03	CI
Alkaloid AD Reports Unaudited Consolidated Earnings Results for the First Half Ended June 2016	16-07-29	CI
Alkaloid Reports Consolidated Earnings Results for the First Quarter Ended March 2016	16-04-28	CI
Alkaloid Plans to Expand Presence in Russian Market Via Serbia	16-03-31	CI

Alkaloid AD Skopje is a Macedonia-based company active in the pharmaceutical sector. It is engaged in the manufacturing and distribution of pharmaceuticals, the processing of herbal materials and the production of cosmetics, tea, chemical products and coating agents. It operates through two divisions: Pharmaceuticals, and Chemicals, Cosmetics and Botanicals. The Companyâs product range includes human drugs, x-ray films, haemodialysis solutions, pharmaceutical raw materials, animal health products, perfumes, household cosmetics, skin, teeth and hair care products, tea and alimentary products. It also operates a development institute for analysis, research and quality control, warehouses and laboratories. The Company operates more than 13 subsidiaries in such countries as Croatia, Serbia, Slovenia, Bosnia and Herzegovina, Bulgaria, Kosovo, the Untied States, Montenegro and the Russian Federation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ALKALOID AD SKOPJE	0.00%	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
CIPLA LIMITED	+12.33%	13.54B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B